Search results
Google site results
Loading...
Wiki results
- ==Cancer Category/Type== ...oid_leukaemia_with_RUNX1::RUNX1T1_fusion Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]'''7 KB (1,022 words) - 14:48, 12 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (804 words) - 13:34, 25 February 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (806 words) - 13:50, 25 February 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (806 words) - 13:50, 25 February 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (806 words) - 13:48, 25 February 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (804 words) - 15:04, 6 October 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (804 words) - 11:50, 25 February 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (806 words) - 12:47, 3 October 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (806 words) - 12:48, 3 October 2023
- Cancer Category/Type ==Cancer Sub-Classification / Subtype==6 KB (902 words) - 12:37, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (804 words) - 12:51, 3 November 2023
- Prashant Deshpande, MD, Sultan Qaboos Comprehensive Cancer Care and Research Center ==Cancer Category/Type==6 KB (815 words) - 12:55, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (808 words) - 12:51, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (808 words) - 12:43, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (807 words) - 11:47, 25 February 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (807 words) - 13:54, 25 February 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (807 words) - 13:54, 25 February 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (808 words) - 12:44, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (808 words) - 12:51, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (808 words) - 12:51, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (808 words) - 12:50, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (808 words) - 12:51, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (808 words) - 12:50, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (809 words) - 12:46, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (809 words) - 12:46, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (814 words) - 12:53, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (814 words) - 12:53, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (816 words) - 12:39, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (821 words) - 12:52, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (761 words) - 12:34, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==7 KB (1,040 words) - 12:57, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (799 words) - 16:28, 4 December 2023
- {{DISPLAYTITLE:T-cell lymphoblastic leukemia with t(7;14)(p15;q32)}} ==Cancer Category/Type==8 KB (1,082 words) - 14:00, 3 November 2023
- {{DISPLAYTITLE:Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6}} ==Cancer Category/Type==6 KB (797 words) - 14:00, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==8 KB (1,058 words) - 12:36, 3 November 2023
- ==Cancer Category/Type== ...lia, but also as AML and they may even present as, or evolve to, precursor T or B lymphoblastic leukaemia/lymphoma with prominent eosinphils." (p.28).10 KB (1,469 words) - 17:05, 11 October 2018
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (826 words) - 12:34, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (880 words) - 12:39, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==8 KB (1,098 words) - 13:48, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (887 words) - 13:51, 25 February 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==7 KB (918 words) - 13:50, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (861 words) - 16:28, 4 December 2023
- ==Cancer Category/Type== ..., hematopoietic and lymphoid cancers (13.8%), and Melanomas (7%) ([https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=kit see COSMIC]).7 KB (1,047 words) - 14:32, 12 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==8 KB (1,165 words) - 12:57, 3 November 2023
- {{DISPLAYTITLE:B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged}} ==Cancer Category/Type==6 KB (910 words) - 13:48, 3 November 2023
- ==Cancer Category/Type== ...AAT/enhancer-binding proteins beta and gamma to modulate the expression of genes involved in cell cycle regulation. It coordinates proliferation arrest and7 KB (1,051 words) - 13:53, 12 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==7 KB (922 words) - 12:55, 3 November 2023
- ==Cancer Category/Type== ...a.io/index.php/T-Lymphoblastic_Leukemia/Lymphoma T-Lymphoblastic Leukemia (T-ALL)]6 KB (805 words) - 12:38, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==7 KB (962 words) - 16:43, 4 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==9 KB (1,185 words) - 12:37, 3 November 2023
- ==General Disease Overview / Description of Cancer Category== *[[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4]]3 KB (360 words) - 16:30, 4 December 2023
- ==Cancer Category/Type== ...ndex.php/HAEM4:T-Lymphoblastic_Leukemia/Lymphoma T-Lymphoblastic Leukemia (T-ALL)]6 KB (840 words) - 16:32, 4 December 2023
- ==General Disease Overview / Description of Cancer Category== *[[B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1]]3 KB (349 words) - 12:37, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==8 KB (1,060 words) - 12:37, 3 November 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,368 words) - 15:12, 22 December 2023
- {{DISPLAYTITLE:B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1}} Cancer Category/Type6 KB (903 words) - 13:48, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==9 KB (1,255 words) - 12:34, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==9 KB (1,372 words) - 12:36, 3 November 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,391 words) - 18:27, 23 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,389 words) - 18:22, 23 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,392 words) - 18:23, 23 December 2023
- ==Cancer Category/Type== ...urr. Biol. 9: 1373-1381, 1999.</ref><ref>Zhang Z, Yuan B, Bao M, Lu N, Kim T, Liu YJ. The helicase DDX41 senses intracellular DNA mediated by the adapto5 KB (787 words) - 14:00, 12 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,434 words) - 10:50, 27 February 2024
- ...riginal page can be found at [[HAEM4:Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype]]. ==Cancer Category / Type==10 KB (1,386 words) - 14:35, 13 December 2023
- {{DISPLAYTITLE:Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes}} ==Cancer Category / Type==11 KB (1,530 words) - 14:34, 13 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==8 KB (1,106 words) - 12:30, 3 November 2023
- ...e 4th edition was Fibrin-Associated Diffuse Large B-cell Lymphoma and didn't have content. ==Cancer Category / Type==10 KB (1,435 words) - 11:55, 23 December 2023
- [[Category:Somatically Mutated Genes]] ...na, MD, M.D. Anderson Cancer Center and Min Fang, MD, PhD, Fred Hutchinson Cancer Research Center8 KB (1,195 words) - 21:24, 6 August 2016
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (797 words) - 12:34, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==8 KB (1,146 words) - 16:24, 4 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,489 words) - 13:37, 25 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,489 words) - 13:38, 25 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,489 words) - 13:43, 25 February 2024
- ==Cancer Category/Type== ...oid_leukaemia_with_RUNX1::RUNX1T1_fusion Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]'''11 KB (1,545 words) - 14:48, 12 December 2023
- ...iginal page can be found at [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3]]. ==Cancer Category / Type==10 KB (1,436 words) - 14:21, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,489 words) - 13:31, 29 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,489 words) - 10:47, 29 January 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,489 words) - 13:39, 25 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,489 words) - 13:41, 25 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,489 words) - 13:42, 25 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,494 words) - 16:44, 4 March 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==10 KB (1,334 words) - 12:32, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==7 KB (898 words) - 12:47, 3 November 2023
- [[File:T(6;9)(p23;q34).png]] ==Cancer Category/Type==10 KB (1,401 words) - 12:32, 3 November 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,460 words) - 13:26, 29 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==10 KB (1,501 words) - 18:38, 27 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==9 KB (1,266 words) - 14:32, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,506 words) - 14:39, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:40, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:21, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:29, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:25, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:30, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:16, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:30, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:27, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:39, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:25, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:19, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:19, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,509 words) - 14:29, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:23, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:41, 13 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==8 KB (1,125 words) - 12:28, 3 November 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:38, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:29, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:33, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:19, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:25, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:24, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:28, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:28, 13 December 2023
- {{DISPLAYTITLE:Subcutaneous panniculitis-like T-cell lymphoma}} ==Cancer Category / Type==11 KB (1,515 words) - 14:40, 13 December 2023
- {{DISPLAYTITLE:Indolent T-lymphoblastic proliferation}} ==Cancer Category / Type==11 KB (1,512 words) - 14:28, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:23, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:24, 13 December 2023
- {{DISPLAYTITLE:Extranodal NK/T-cell lymphoma}} ==Cancer Category / Type==11 KB (1,515 words) - 14:25, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:32, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:32, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:27, 13 December 2023
- {{DISPLAYTITLE:Peripheral T-cell lymphoma, NOS}} ==Cancer Category / Type==11 KB (1,515 words) - 14:36, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:39, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:33, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,527 words) - 14:18, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,521 words) - 14:17, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:31, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,520 words) - 11:21, 23 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==6 KB (828 words) - 16:28, 4 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,521 words) - 14:16, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:39, 13 December 2023
- {{DISPLAYTITLE:T-lymphoblastic leukaemia / lymphoma, NOS}} ==Cancer Category / Type==11 KB (1,517 words) - 15:33, 22 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,521 words) - 14:27, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,524 words) - 15:52, 20 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:26, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:35, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,517 words) - 15:33, 22 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:36, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,533 words) - 14:16, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:24, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,524 words) - 14:34, 13 December 2023
- {{DISPLAYTITLE:Primary cutaneous peripheral T-cell lymphoma, NOS}} ==Cancer Category / Type==11 KB (1,521 words) - 14:38, 13 December 2023
- {{DISPLAYTITLE:Primary cutaneous gamma/delta T-cell lymphoma}} ==Cancer Category / Type==11 KB (1,521 words) - 14:38, 13 December 2023
- {{DISPLAYTITLE:T-cell/histiocyte-rich large B-cell lymphoma}} ==Cancer Category / Type==11 KB (1,518 words) - 14:41, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,521 words) - 14:29, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,521 words) - 14:36, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,530 words) - 14:33, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,529 words) - 15:31, 22 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,524 words) - 14:39, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,530 words) - 14:31, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,527 words) - 14:20, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,527 words) - 14:21, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,524 words) - 14:29, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,527 words) - 14:28, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==13 KB (1,759 words) - 14:19, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,530 words) - 14:39, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,527 words) - 14:38, 13 December 2023
- ...AYTITLE:Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma}} ==Cancer Category / Type==11 KB (1,530 words) - 14:37, 13 December 2023
- {{DISPLAYTITLE:Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis}} ==Cancer Category / Type==11 KB (1,530 words) - 14:37, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,536 words) - 14:37, 13 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==7 KB (939 words) - 13:55, 3 November 2023
- T. Niroshi Senaratne, UCLA ==Cancer Category/Type==8 KB (1,186 words) - 12:27, 3 November 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,539 words) - 14:27, 13 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==8 KB (1,171 words) - 14:00, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==8 KB (1,162 words) - 13:41, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==7 KB (960 words) - 12:36, 3 November 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,545 words) - 14:30, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,556 words) - 14:28, 13 December 2023
- ==Cancer Category/Type== ...substitution mutations, is found at a low level in many cancers ([https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=etv6 see COSMIC]); it is more prominen9 KB (1,371 words) - 14:18, 12 December 2023
- ==Cancer Category/Type== ...ith Chronic Myeloid Leukemia have a Philadelphia chromosome resulting from t(9;22)(q34.1;q11.2), which is a reciprocal translocation between chromosome12 KB (1,749 words) - 13:50, 12 December 2023
- ==General Disease Overview / Description of Cancer Category== ...[HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion|B-ALL with t(9;22)(q34.1;q11.2); BCR-ABL1]]3 KB (430 words) - 16:30, 4 December 2023
- T. Niroshi Senaratne, UCLA ==Cancer Category/Type==9 KB (1,224 words) - 13:40, 3 November 2023
- ==General Disease Overview / Description of Cancer Category== ...hoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1|B-ALL with t(9;22)(q34.1;q11.2); BCR-ABL1]]3 KB (412 words) - 12:36, 3 November 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,601 words) - 15:20, 20 December 2023
- {{DISPLAYTITLE:B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1}} ==Cancer Category/Type==8 KB (1,186 words) - 13:49, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==12 KB (1,750 words) - 12:32, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==7 KB (996 words) - 16:30, 4 December 2023
- ==Cancer Category/Type== *[[Mature T- and NK-cell Neoplasms]]13 KB (1,809 words) - 12:49, 3 November 2023
- ==Cancer Category/Type== Mature T-cell neoplasm / Cutaneous T-cell lymphoma11 KB (1,582 words) - 12:50, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==9 KB (1,317 words) - 12:28, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==10 KB (1,367 words) - 12:56, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==7 KB (947 words) - 12:55, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==9 KB (1,239 words) - 12:56, 3 November 2023
- ==Cancer Category/Type== Mature T-cell neoplasm / Cutaneous T-cell lymphoma11 KB (1,621 words) - 16:40, 4 December 2023
- {{DISPLAYTITLE:Hepatosplenic T-cell Lymphoma}} ==Cancer Category/Type==13 KB (1,849 words) - 16:40, 4 December 2023
- {{DISPLAYTITLE:Intestinal T-cell lymphoma, NOS}} ...mplate on 2023-12-07. The original page can be found at [[HAEM4:Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)]].13 KB (1,756 words) - 14:28, 13 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==11 KB (1,531 words) - 12:34, 3 November 2023
- ==General Disease Overview / Description of Cancer Category== ...lymphoblastic lymphomas (T-LBL) <ref name=":0">Borowitz MJ, et al., (2016).T-lymphoblastic leukemia/lymphoma, in World Health Organization Classificatio7 KB (956 words) - 12:38, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==8 KB (1,110 words) - 12:34, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==10 KB (1,408 words) - 16:44, 4 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==10 KB (1,360 words) - 11:38, 14 November 2023
- '''Cancer Category/Type''' '''Cancer Sub-Classification/Subtype'''7 KB (872 words) - 15:02, 12 December 2023
- ==General Disease Overview / Description of Cancer Category== ...lymphoblastic lymphomas (T-LBL) <ref name=":0">Borowitz MJ, et al., (2016).T-lymphoblastic leukemia/lymphoma, in World Health Organization Classificatio7 KB (959 words) - 16:32, 4 December 2023
- ==Cancer Category/Type== Nearly universal involvement in diverse cancer types.11 KB (1,625 words) - 18:14, 5 January 2019
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==9 KB (1,281 words) - 16:44, 4 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype <ref name=":0" />==7 KB (1,001 words) - 12:41, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==7 KB (986 words) - 16:43, 4 December 2023
- {{DISPLAYTITLE:Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged}} ==Cancer Category/Type==9 KB (1,384 words) - 16:30, 4 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==8 KB (1,136 words) - 16:28, 4 December 2023
- {{DISPLAYTITLE:B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1}} ==Cancer Category/Type==8 KB (1,060 words) - 13:48, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype <ref name=":0" />==7 KB (1,040 words) - 13:51, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==11 KB (1,502 words) - 12:43, 3 November 2023
- {{DISPLAYTITLE:Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1}} ==Cancer Category/Type==10 KB (1,337 words) - 13:45, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==9 KB (1,194 words) - 12:29, 3 November 2023
- {{DISPLAYTITLE:Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214}} [[File:T(6;9)(p23;q34).png]]10 KB (1,402 words) - 13:44, 3 November 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==14 KB (2,002 words) - 14:18, 13 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==13 KB (1,782 words) - 12:32, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==12 KB (1,664 words) - 12:36, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==11 KB (1,544 words) - 16:36, 4 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==10 KB (1,397 words) - 12:33, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==11 KB (1,516 words) - 12:29, 3 November 2023
- Hui Chen, MD, PhD, The University of Texas MD Anderson Cancer Center ==Cancer Category/Type==9 KB (1,336 words) - 16:42, 16 April 2024
- ...liferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)}} ==Cancer Category/Type==9 KB (1,239 words) - 13:42, 3 November 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==14 KB (1,992 words) - 14:26, 13 December 2023
- ...iginal page can be found at [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1]]. Cancer Category/Type14 KB (1,917 words) - 14:20, 13 December 2023
- [[File:T(6;9)(p23;q34).png]] ==Cancer Category/Type==10 KB (1,452 words) - 10:55, 12 September 2022
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==15 KB (2,064 words) - 14:18, 13 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==9 KB (1,294 words) - 12:44, 3 November 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==15 KB (2,127 words) - 14:23, 13 December 2023
- ...iginal page can be found at [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged]]. ==Cancer Category / Type==12 KB (1,796 words) - 14:21, 13 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==11 KB (1,435 words) - 13:46, 3 November 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==15 KB (2,146 words) - 12:07, 23 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==11 KB (1,558 words) - 16:23, 4 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==16 KB (2,256 words) - 14:31, 13 December 2023
- ...ssue and bone tumours. Lyon (France): International Agency for Research on Cancer; 2020. (WHO classification of tumours series, 5th ed.; vol. 3). <nowiki>htt !Chromosomal Rearrangement!!Genes in Fusion (5’ or 3’ Segments)!!Pathogenic Derivative!!Prevalence13 KB (1,889 words) - 14:19, 14 March 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==15 KB (2,002 words) - 12:34, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==9 KB (1,340 words) - 12:38, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==10 KB (1,336 words) - 13:54, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==9 KB (1,256 words) - 16:28, 4 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==8 KB (1,127 words) - 12:36, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==10 KB (1,335 words) - 12:31, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==10 KB (1,382 words) - 16:32, 4 December 2023
- Thank you for volunteering to help curate the Compendium of Cancer Genome Aberrations (CCGA)! Your help will make this resource a valuable to .... The CCGA is interested in the curation of genes/mutations that arise in cancer. However, the dividing line between "Gene/Protein/Mutation" information an23 KB (3,717 words) - 14:25, 12 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==13 KB (1,743 words) - 12:43, 3 November 2023
- ==Cancer Category/Type== * [[Mature T- and NK-cell Neoplasms]]9 KB (1,288 words) - 12:52, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==8 KB (1,169 words) - 16:30, 4 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==13 KB (1,771 words) - 16:22, 6 May 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==13 KB (1,783 words) - 16:35, 4 December 2023
- T. Niroshi Senaratne, UCLA ==Cancer Category / Type==16 KB (2,266 words) - 14:39, 13 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==12 KB (1,774 words) - 12:56, 3 November 2023
- ==Cancer Category/Type== * [[HAEM4:Mature T- and NK-cell Neoplasms]]10 KB (1,333 words) - 16:41, 4 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==10 KB (1,431 words) - 12:56, 3 November 2023
- ==Cancer Category/Type== ...ith Chronic Myeloid Leukemia have a Philadelphia chromosome resulting from t(9;22)(q34.1;q11.2), which is a reciprocal translocation between chromosome12 KB (1,695 words) - 13:43, 12 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==13 KB (1,816 words) - 14:00, 3 November 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==17 KB (2,323 words) - 14:34, 13 December 2023
- {{DISPLAYTITLE:Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3}} ==Cancer Category/Type==12 KB (1,744 words) - 13:44, 3 November 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==10 KB (1,328 words) - 12:43, 3 November 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==18 KB (2,507 words) - 15:34, 20 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==10 KB (1,475 words) - 13:59, 3 November 2023
- ...www.ncbi.nlm.nih.gov/pubmed/?term=30377088 30377088]] with permission from Cancer Genetics. ''See [[MDS, MDS/MPN and MPN Tables: Recurrent Genomic Alteration ==General Disease Overview / Description of Cancer Category==4 KB (541 words) - 16:23, 4 December 2023
- ...iginal page can be found at [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1]]. ==Cancer Category / Type==15 KB (2,139 words) - 14:20, 13 December 2023